CUSIP 984241109COMYMABUSDQ3 2025
40 filings · latest Nov 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Brooklyn Investment Group | 16.1K | $75.5K |
| 2 | Ifp Advisors, Inc | 332 | $2.9K |
| 4 | Nov 14, 2025 | Caligan Partners LP | 13G/A | — | 49 | SEC |
| 5 | Nov 13, 2025 | Glazer Capital, LLC | 13G/A | — | — | SEC |
| 6 | Aug 20, 2025 | Acorn Bioventures, L.P. | 13G/A | 6.2% | 2.80M | SEC |
| 7 | Aug 15, 2025 | Acorn Bioventures, L.P. | 13G/A | 7.0% | 3.10M | SEC |
| 8 | Aug 15, 2025 | Glazer Capital, LLC | 13G | 5.8% | 2.65M | SEC |
| 9 | Aug 12, 2025 | Beryl Capital Management LLC | 13G | 9.0% | — | SEC |
| 10 | May 14, 2025 | Caligan Partners LP | 13G | 5.2% | 2.34M | SEC |
See the full Schedule 13D/13G history for Y-Mabs Therapeutics Inc.
Unlock full history